Condition: DCIS · Breast Cancer · Breast Neoplasms · Sponsor: Uppsala University
The trial aims to investigate the use of superparamagnetic iron oxide (SPIO) nanoparticles as a tracer for delayed sentinel lymph node dissection (d-SLND) in patients where upfront axillary surgery (SLND) is oncologically deemed unnecessary and should be avoided. This includes but is not limited to patients with a preoperative diagnosis of ductal cancer in situ of the breast (DCIS), an unclear BIRADS 4-5 planned for diagnostic excision or women planned for risk reducing mastectomy. SPIO is injected in the primary operation, and should final specimen pathology demonstrate invasive breast cancer, only then is an operation in the axilla (d-SLND) performed.
This description comes directly from the study's public registry record.
Andreas Karakatsanis, PhD · +46765864826 · andreas.karakatsanis@surgsci.uu.se
Fredrik Wärnberg, PhD · fredrik.warnberg@vgregion.se
Always discuss trial participation with your own doctor first.
| Baylor College Of Medicine | Houston, Texas, United States | Recruiting |
| The University of Hong Kong-Shenzhen Hospital | Hong Kong, Hong Kong | Recruiting |
| Falun Lasarett | Falun, Dalarna County, Sweden | Recruiting |
| Växjö County Hospital | Vaxjo, Kronoberg County, Sweden | Recruiting |
| Skåne University Hospital | Lund, Skåne County, Sweden | Recruiting |
| Västmanland County Hospital | Västerås, Västmanland County, Sweden | Recruiting |
| Sahlgrenska University Hospital | Gothenburg, Västra Götaland County, Sweden | Recruiting |
| Uppsala University Hospital | Uppsala, Sweden | Recruiting |
| Linköping University Hospital | Linköping, Östra Götaland, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04722692